FDA Drug Application (011665) for MESTINON by VALEANT PHARMS LLC

Back to FDA Applications sponsored by VALEANT PHARMS LLC

Application Number011665
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMESTINON
Active IngredientPYRIDOSTIGMINE BROMIDE

Active IngredientCount
List of drugs with Active Ingredient PYRIDOSTIGMINE BROMIDE3


Back to FDA Applications sponsored by VALEANT PHARMS LLC